Table 5.
Ingenuity canonical pathways | -log(p-value) | p-value | Ratio | z-scorea | Number of affected molecules | Total number of moleculesb |
---|---|---|---|---|---|---|
AMPK Signaling | 4.00 | 0.0001 | 0.183 | −0.471 | 30 | 164 |
Hepatic Fibrosis/Hepatic Stellate Cell Activation | 3.76 | 0.0002 | 0.180 | 29 | 161 | |
Acetate Conversion to Acetyl-CoA | 3.55 | 0.0003 | 0.800 | 4 | 5 | |
Ovarian Cancer Signaling | 3.45 | 0.0004 | 0.190 | 23 | 121 | |
cAMP-mediated signaling | 3.25 | 0.0006 | 0.162 | 1.257 | 32 | 197 |
Mitotic Roles of Polo-Like Kinase | 3.08 | 0.0008 | 0.236 | 13 | 55 | |
Glioma Signaling | 3.04 | 0.0009 | 0.198 | 0.258 | 18 | 91 |
Cell Cycle Control of Chromosomal Replication | 2.87 | 0.0013 | 0.308 | 8 | 26 | |
Xenobiotic Metabolism Signaling | 2.79 | 0.0016 | 0.151 | 33 | 218 | |
LXR/RXR Activation | 2.69 | 0.0020 | 0.181 | 0.775 | 19 | 105 |
Calcium Signaling | 2.62 | 0.0024 | 0.161 | 1.698 | 25 | 155 |
Eumelanin Biosynthesis | 2.59 | 0.0026 | 0.750 | 3 | 4 | |
FXR/RXR Activation | 2.50 | 0.0032 | 0.174 | 19 | 109 | |
ATM Signaling | 2.50 | 0.0032 | 0.214 | −1.265 | 12 | 56 |
Ethanol Degradation IV | 2.46 | 0.0035 | 0.333 | 6 | 18 | |
LPS/IL-1 Mediated Inhibition of RXR Function | 2.45 | 0.0035 | 0.151 | 0.378 | 28 | 185 |
Glioma Invasiveness Signaling | 2.43 | 0.0037 | 0.211 | 0.577 | 12 | 57 |
GADD45 Signaling | 2.33 | 0.0047 | 0.316 | 6 | 19 | |
Superpathway of Cholesterol Biosynthesis | 2.31 | 0.0049 | 0.280 | 7 | 25 | |
Oxidative Ethanol Degradation III | 2.26 | 0.0055 | 0.357 | 5 | 14 |
az-score reflects activation, if values are positive and inactivation, if values are negative
bTotal number of molecules present on the Bovine Gene 1.0 ST Array that are assigned to specific canonical pathways by IPA